1·GM-SCF is already in use in humans as a therapy for neutropenia, and Dr. Shams hopes to eventually test its effectiveness in clinical trials for preventing or treating flu exposure.
GM - SCF作为对嗜中性白血球减少症的治疗早已在人体应用，Shams博士希望最终测试它在预防和治疗流感的临床试验的效力。
2·Lower performance status was associated with an increased need for dose reductions and an increased incidence of grade 3-4 neutropenia.
较低的活动能力与剂量减少的上升、3 - 4级嗜中性白血球减少症发生率的上升有关。
3·"Neutropenia" is the term for a decrease below normal in the concentration of neutrophils.
“嗜中性白血球减少症”是指中性粒细胞浓度低于正常值的现象。